Home>Topics>>Can The Rally In Biotechs Keep Its Momentum?
Can The Rally In Biotechs Keep Its Momentum?
Healthcare Sector and Stocks Analysis from Seeking Alpha
Fri, 14 Feb 2014
By Mitchell Clark The last time we looked at Alexion Pharmaceuticals, Inc. ( ALXN ), the position was trading around $121.00 a share. Now, it's $175.00 a share, and once again, the company reported outstanding financial results from its "Soliris" wonder-drug. This stock has been a powerhouse wealth ...
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.